[HTML][HTML] Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7 …
DJ Isaacman, ED McIntosh, RR Reinert - International Journal of Infectious …, 2010 - Elsevier
OBJECTIVES: The overall reported burden of invasive pneumococcal disease (IPD) varies
among countries in Europe. This review describes the epidemiology and serotype …
among countries in Europe. This review describes the epidemiology and serotype …
Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology
MA Fletcher, HJ Schmitt, M Syrochkina… - European journal of …, 2014 - Springer
This review evaluates the serotype epidemiology of complicated pneumococcal pneumonia
(CPP) during the period 1990–2012. PubMed and EMBASE were searched using the terms …
(CPP) during the period 1990–2012. PubMed and EMBASE were searched using the terms …
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster …
AA Palmu, J Jokinen, D Borys, H Nieminen… - The Lancet, 2013 - thelancet.com
Summary Background The Finnish Invasive Pneumococcal disease (FinIP) vaccine trial was
designed to assess the effectiveness of a pneumococcal vaccine containing ten serotype …
designed to assess the effectiveness of a pneumococcal vaccine containing ten serotype …
Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007
A Fenoll, JJ Granizo, L Aguilar… - Journal of clinical …, 2009 - Am Soc Microbiol
Temporal trends of serotypes from invasive pneumococcal disease (IPD) in Spain from 1979
to September 2007 under antibiotic and vaccine pressure were analyzed. A significant trend …
to September 2007 under antibiotic and vaccine pressure were analyzed. A significant trend …
[HTML][HTML] Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands
GD Rodenburg, SC de Greeff… - Emerging infectious …, 2010 - ncbi.nlm.nih.gov
In the Netherlands, the 7-valent pneumococcal conjugate vaccine (PCV-7) was
implemented in a 3+ 1-dose schedule in the national immunization program for infants born …
implemented in a 3+ 1-dose schedule in the national immunization program for infants born …
Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction …
Background. A dramatic decrease in the incidence of invasive pneumococcal disease (IPD)
was observed among children and adults in the United States after the introduction of the 7 …
was observed among children and adults in the United States after the introduction of the 7 …
Global prevailing and emerging pediatric pneumococcal serotypes
EDG McIntosh, RR Reinert - Expert review of vaccines, 2011 - Taylor & Francis
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths among
children younger than 5 years of age worldwide. The 7-valent pneumococcal conjugate …
children younger than 5 years of age worldwide. The 7-valent pneumococcal conjugate …
[HTML][HTML] Pediatric pneumococcal serotypes in 4 European countries
G Hanquet, E Kissling, A Fenoll, R George… - Emerging infectious …, 2010 - ncbi.nlm.nih.gov
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain,
Belgium, and England and Wales (United Kingdom), invasive disease from non-PCV7 …
Belgium, and England and Wales (United Kingdom), invasive disease from non-PCV7 …
Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome
S Rückinger, R von Kries, A Siedler… - The Pediatric …, 2009 - journals.lww.com
Background: Invasive pneumococcal disease (IPD) in children may manifest as
bacteremia/sepsis, bacteremic pneumonia, or meningitis, with serious outcomes that include …
bacteremia/sepsis, bacteremic pneumonia, or meningitis, with serious outcomes that include …
Vaccination Drives Changes in Metabolic and Virulence Profiles of Streptococcus pneumoniae
The bacterial pathogen, Streptococcus pneumoniae (the pneumococcus), is a leading cause
of life-threatening illness and death worldwide. Available conjugate vaccines target only a …
of life-threatening illness and death worldwide. Available conjugate vaccines target only a …